scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/S1537-1891(02)00253-7 |
P698 | PubMed publication ID | 12487033 |
P2093 | author name string | Anne Burke-Gaffney | |
Richard G Bogle | |||
Alison V S Brooks | |||
P2860 | cites work | Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes | Q22253300 |
Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells | Q24563090 | ||
Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
Chemokines and disease | Q28200068 | ||
Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease | Q28206251 | ||
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia | Q28379241 | ||
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta | Q28379553 | ||
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) | Q29615693 | ||
Chemokines--chemotactic cytokines that mediate inflammation | Q29616433 | ||
Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice | Q30304058 | ||
Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. | Q30305868 | ||
VCAM-1 is critical in atherosclerosis | Q30307456 | ||
Adhesion molecules and cellular biomechanical changes in acute lung injury: Giles F. Filley Lecture | Q33698432 | ||
New insights into the pharmacodynamic and pharmacokinetic properties of statins. | Q33832848 | ||
MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. | Q33844451 | ||
Interleukin-8 and its receptor CXCR2 in atherosclerosis | Q33942002 | ||
Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation | Q34088380 | ||
Chemokines: immunology's high impact factors | Q34139595 | ||
Monocyte chemoattractant protein-1 in human atheromatous plaques | Q34203056 | ||
Ligands for peroxisome proliferator-activated receptor inhibit monocyte CCR2 expression stimulated by plasma lipoproteins | Q34204700 | ||
Minimally modified low density lipoprotein is biologically active in vivo in mice | Q34265672 | ||
Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells | Q34509942 | ||
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis | Q34662335 | ||
Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma | Q37270009 | ||
A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice | Q37377448 | ||
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions | Q37532544 | ||
Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae | Q37876716 | ||
Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells | Q40855085 | ||
Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors | Q40922775 | ||
Oxidized low-density lipoprotein induces the production of interleukin-8 by endothelial cells | Q41146043 | ||
Mononuclear Cell Adherence Induces Neutrophil Chemotactic Factor/Interleukin-8 Gene Expression | Q41156229 | ||
Statins do more than just lower cholesterol | Q41169571 | ||
Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction | Q41689431 | ||
Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice | Q41745082 | ||
PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells | Q42267879 | ||
Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma | Q42517095 | ||
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients | Q42556657 | ||
Aspirin intolerance and related syndromes: a multidisciplinary approach. Proceedings Of an international symposium organised by the catholic university of the sacred heart and the european network on aspirin induced asthma (aiane), rome, 11-13 novem | Q42585348 | ||
Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques | Q42857233 | ||
Interleukin-8 as a macrophage-derived mediator of angiogenesis | Q44053300 | ||
Human vascular smooth muscle cells possess functional CCR5. | Q44837410 | ||
Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. | Q46754875 | ||
Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
Modulation of IL-8 receptor expression on purified human T lymphocytes is associated with changed chemotactic responses to IL-8. | Q53466256 | ||
Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. | Q54337264 | ||
Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells | Q56890926 | ||
Distinct T Cell/Renal Tubular Epithelial Cell Interactions Define Differential Chemokine Production: Implications for Tubulointerstitial Injury in Chronic Glomerulonephritides | Q57232096 | ||
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions | Q59064735 | ||
Downregulation by tumor necrosis factor-α of monocyte CCR2 expression and monocyte chemotactic protein-1-induced transendothelial migration is antagonized by oxidized low-density lipoprotein | Q63915279 | ||
The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. | Q64928622 | ||
Monocyte adherence to the subendothelial basement membrane increases interleukin-8 gene expression and antigen release | Q70842312 | ||
Juxtacrine stimulation of cytokine production in cocultures of human dermal fibroblasts and T cells | Q71731515 | ||
Anti-atheromatous effects of fenofibrate, a hypolipidemic drug. I: Anti-atheromatous effects are independent of its hypolipidemic effect in cholesterol-fed rabbits | Q71818437 | ||
Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells | Q72018966 | ||
Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody | Q72080088 | ||
Induction of monocyte chemoattractant protein-1 synthesis in human monocytes during transendothelial migration in vitro | Q72187792 | ||
Suppressive role of endogenous endothelial monocyte chemoattractant protein-1 on monocyte transendothelial migration in vitro | Q72235810 | ||
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association | Q72415283 | ||
Adherence in combination with lipopolysaccharide, tumor necrosis factor or interleukin-1 beta potentiates the induction of monocyte-derived interleukin-8 | Q72548333 | ||
Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells | Q73076629 | ||
Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction | Q73081786 | ||
Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation | Q73134578 | ||
Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes | Q73176765 | ||
Pravastatin down-regulates inflammatory mediators in human monocytes in vitro | Q73337591 | ||
Cell to cell interaction between mesangial cells and macrophages induces the expression of monocyte chemoattractant protein-1 through nuclear factor-kappaB activation | Q73525112 | ||
Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE | Q73575738 | ||
IL-8 is an angiogenic factor in human coronary atherectomy tissue | Q73624327 | ||
Localisation of mRNA for JE/MCP-1 and its receptor CCR2 in atherosclerotic lesions of the ApoE knockout mouse | Q73644725 | ||
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group | Q73804303 | ||
Interactions of lymphocytes from patients with psoriatic arthritis or healthy controls and cultured endothelial cells | Q73944979 | ||
Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells | Q73966728 | ||
Inhibition of monocyte chemotactic protein-1 synthesis by statins | Q74045131 | ||
Hypochlorite-modified LDL: chemotactic potential and chemokine induction in human monocytes | Q74063393 | ||
Human vascular smooth muscle cells express receptors for CC chemokines | Q74351441 | ||
Release of chemoattractants for human monocytes from endothelial cells by interaction with neutrophils | Q77111409 | ||
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice | Q77231603 | ||
Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice | Q77340592 | ||
Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells | Q77450629 | ||
HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis | Q77700153 | ||
Thiazolidinedione inhibits the production of monocyte chemoattractant protein-1 in cytokine-treated human vascular endothelial cells | Q78020356 | ||
Expression of CCR2 by endothelial cells : implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium | Q78233810 | ||
P433 | issue | 5 | |
P921 | main subject | atherosclerosis | Q12252367 |
P304 | page(s) | 283-292 | |
P577 | publication date | 2002-05-01 | |
P1433 | published in | Vascular Pharmacology | Q7916446 |
P1476 | title | Regulation of chemokine expression in atherosclerosis | |
P478 | volume | 38 |
Q48268328 | Acute stress evokes selective mobilization of T cells that differ in chemokine receptor expression: a potential pathway linking immunologic reactivity to cardiovascular disease |
Q58587144 | Adipose tissue expression of CCL19 chemokine is positively associated with insulin resistance |
Q26822655 | Atherosclerosis: process, indicators, risk factors and new hopes |
Q36676660 | CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? |
Q36482911 | Hematopoietic G-protein-coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor-knockout mice |
Q38083555 | Inflammation and immune system interactions in atherosclerosis |
Q53676505 | Lipopolysaccharide-induced cytokine and chemokine expression in human carotid lesions. |
Q37234653 | Loss of CCR5 results in glucose intolerance in diet-induced obese mice |
Q42491380 | Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors |
Q44807760 | Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways |
Q37415406 | Regulation of angiogenesis by oxygen sensing mechanisms |
Q27012949 | Roles of microRNAs in atherosclerosis and restenosis |
Q51499146 | Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR-PSOX gene. |
Q38450708 | Transcriptional profiling of human smooth muscle cells infected with gingipain and fimbriae mutants of Porphyromonas gingivalis |
Search more.